Billiontoone (NASDAQ:BLLN – Get Free Report) and CVS Health (NYSE:CVS – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings.
Earnings and Valuation
This table compares Billiontoone and CVS Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Billiontoone | $436.87 million | 11.36 | $7.45 million | $0.92 | 114.29 |
| CVS Health | $402.07 billion | 0.28 | $1.77 billion | $8.59 | 10.40 |
CVS Health has higher revenue and earnings than Billiontoone. CVS Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
80.7% of CVS Health shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by insiders. Comparatively, 0.9% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares Billiontoone and CVS Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Billiontoone | 10.95% | 9.16% | 6.78% |
| CVS Health | 2.62% | 13.65% | 4.20% |
Analyst Recommendations
This is a summary of recent recommendations for Billiontoone and CVS Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Billiontoone | 1 | 3 | 7 | 0 | 2.55 |
| CVS Health | 0 | 2 | 23 | 0 | 2.92 |
Billiontoone currently has a consensus price target of $124.38, indicating a potential upside of 18.28%. CVS Health has a consensus price target of $107.54, indicating a potential upside of 20.34%. Given CVS Health’s stronger consensus rating and higher possible upside, analysts clearly believe CVS Health is more favorable than Billiontoone.
Summary
CVS Health beats Billiontoone on 8 of the 13 factors compared between the two stocks.
About Billiontoone
BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.
About CVS Health
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
